Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Barr

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Oncotarget|October 27, 2017
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLCLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Translational Lung Cancer Research|May 20, 2021
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancerLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Cancer Letters|August 30, 2020
Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growthLulu Hu, Dachuan Shen, Dapeng Liang, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLCSarah-Louise Ryan, Sam Beard, Martin P Barr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2025
Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective CohortCiara S McNevin, Anna Keogh, Mutaz Mohammed Nur, et al.
Bone Marrow Transplantation|October 18, 2011
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignanciesT L Kindwall-Keller, Y Hegerfeldt, H J Meyerson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)B S Dabaja, A D Zelenetz, A K Ng, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLCCeline Mascaux, Triparna Sen, Montse Sanchez-Cespedes, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2025
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN studyDavid O'Reilly, Anthony O'Grady, Conor Hayes, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Oncotarget|October 27, 2017
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLCLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Translational Lung Cancer Research|May 20, 2021
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancerLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Cancer Letters|August 30, 2020
Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growthLulu Hu, Dachuan Shen, Dapeng Liang, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLCSarah-Louise Ryan, Sam Beard, Martin P Barr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2025
Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective CohortCiara S McNevin, Anna Keogh, Mutaz Mohammed Nur, et al.
Bone Marrow Transplantation|October 18, 2011
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignanciesT L Kindwall-Keller, Y Hegerfeldt, H J Meyerson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)B S Dabaja, A D Zelenetz, A K Ng, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLCCeline Mascaux, Triparna Sen, Montse Sanchez-Cespedes, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2025
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN studyDavid O'Reilly, Anthony O'Grady, Conor Hayes, et al.
Pageof 16